Pnd7 - An Exploratory Analysis of Efficacy of Ocrelizumab for Multiple Sclerosis Patients With Increased Disability

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.1974
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Ocrelizumab in the Treatment of Primary-Progressive Multiple Sclerosis

Medical Council
2018English

Pnd38 - Economic Impact of Multiple Sclerosis in Patients With Low Physical Disability

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Assessing Clinical Correlates of Self-Rated Disability in Patients With Multiple Sclerosis

Multiple Sclerosis Journal - Experimental, Translational and Clinical
2015English

Increased Serum Levels of C21 Steroids in Female Patients With Multiple Sclerosis

Physiological Research
MedicinePhysiology
2015English

Evaluating Optic Nerve Diameter as a Possible Biomarker for Disability in Patients With Multiple Sclerosis

Neuropsychiatric Disease and Treatment
2019English

Increased Intrathecal High-Avidity Anti-Tau Antibodies in Patients With Multiple Sclerosis

PLoS ONE
Multidisciplinary
2011English

Infratentorial Lesions Predict Long-Term Disability in Patients With Initial Findings Suggestive of Multiple Sclerosis

Archives of Neurology
2004English

Pnd98 - Determining the Value of Ocrevus® (Ocrelizumab) for the Treatment of Multiple Sclerosis in Spain by Multi-Criteria Decision Analysis (Mcda)

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Guided Imagery Improves Mood, Fatigue, and Quality of Life in Individuals With Multiple Sclerosis: An Exploratory Efficacy Trial of Healing Light Guided Imagery

Journal of Evidence-Based Integrative Medicine
Alternative MedicineComplementary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy